Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 17, 2024Journal of Allergy and Clinical ImmunologyOpen Access

Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ESEileen W StalmanLWLuuk WieskeJKJim Keijser

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stalman et al. (2024) studied this question.

synapsesocial.com/papers/68e699b3b6db64358761fb3fhttps://doi.org/10.1016/j.jaci.2024.04.031
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Omicron infection enhances Delta antibody immunity in vaccinated persons2022 · 91 citations
  2. 2Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases2022 · 23 citations
  3. 3SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis2022 · 20 citations
  4. 4Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection2021 · 805 citations
  5. 5Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab2022 · 30 citations